Insulin-like growth factor I is the key growth factor in serum that protects neuroblastoma cells from hyperosmotic-induced apoptosis

Journal of Cellular Physiology

Volumn 182, Issue 1, 2000, Pages 24-32

  Van Golen, Cynthia M ^a   Feldman, Eva L ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASP3 PROTEIN, HUMAN; CASPASE; CASPASE 3; DNA FRAGMENT; GROWTH PROMOTOR; MANNITOL; PLASMA PROTEIN; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL MEMBRANE POTENTIAL; CELL SURVIVAL; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; INTRACELLULAR MEMBRANE; METABOLISM; MITOCHONDRION; MOLECULAR WEIGHT; NERVE CELL; NEUROBLASTOMA; OSMOLARITY; PATHOLOGY; PHYSIOLOGY;

APOPTOSIS; BLOOD PROTEINS; CASPASE 3; CASPASES; CELL SURVIVAL; DNA FRAGMENTATION; ENZYME ACTIVATION; GROWTH SUBSTANCES; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTRACELLULAR MEMBRANES; MANNITOL; MEMBRANE POTENTIALS; MITOCHONDRIA; MOLECULAR WEIGHT; NEUROBLASTOMA; NEURONS; OSMOLAR CONCENTRATION; RECEPTOR, IGF TYPE 1; TUMOR CELLS, CULTURED;

EID: 0033987491     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(200001)182:1<24::AID-JCP3>3.0.CO;2-6     Document Type: Article

References (12)

1. Biedler JL, Spengler BA, Tien-ding C, Ross RA. 1988. Transdifferentiation of human neuroblastoma cells results in coordinate loss of neuronal and malignant properties. Adv Neuroblastoma Res 2:265-276.
2. Brodeur GM, Maris JM, Yamashiro DJ, Hogarty MD, White PS. 1997. Biology and genetics of human neuroblastomas. J Pediatr Hematol Oncol 19:93-101.
3. Bunone G, Mariotti A, Compagni A, Morandi E, Della Valle G. 1997. Induction of apoptosis by p75 neurotrophin receptor in human neuroblastoma cells. Oncogene 14:1463-1470.
4. Cameron NE, Cotter MA, Low PA. 1991. Nerve blood flow in early experimental diabetes in rats: relation to conduction deficits. Am J Physiol 216:E1-8.
5. Castleberry RP. 1997. Biology and treatment of neuroblastoma. Pediatr Clin North Am 44:919-936.
6. Cheng H-L Feldman EL. 1998. Bi-directional regulation of p38 kinase and c-Jun N-terminal protein kinase by insulin-like growth factor-I. J Biol Chem 273:14560-14565.
7. L function upstream of the CED-3-like apoptotic proteases. J Biol Chem 271:4573-4576.
8. Cianfarani S, Rossi P. 1997. Neuroblastoma and insulin-like growth factor system - New insights and clinical perspectives. Eur J Pediatr 156:256-261.
9. Ciccarone V, Spengler BA, Meyers MB, Biedler JL, Ross RA. 1989. Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages. Cancer Res 49:219-225.
10. da Motta LA, Galli P, Piva F, Maggi R. 1997. Effects of epidermal growth factor on the [3H]-thymidine uptake in the SK-N-SH and SH-SY5Y human neuroblastoma cell lines. Arq Neuropsiquiatr 55: 444-451.
11. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME. 1997. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231-241.
12. del Peso L, Gonzalez-Garcia M, Page C, Herrera R, Nunez G. 1997. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278:687-689.